SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367920-20-000037
Filing Date
2020-08-06
Accepted
2020-08-06 07:11:11
Documents
16
Period of Report
2020-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cnce-20200806.htm   iXBRL 8-K 50466
2 EX-99.1 q220earningsrelease.htm EX-99.1 106609
8 cnceimagea0111.jpg GRAPHIC 7277
  Complete submission text file 0001367920-20-000037.txt   323925

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnce-20200806.xsd EX-101.SCH 2438
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cnce-20200806_cal.xml EX-101.CAL 720
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnce-20200806_def.xml EX-101.DEF 1653
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnce-20200806_lab.xml EX-101.LAB 24935
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnce-20200806_pre.xml EX-101.PRE 13200
9 EXTRACTED XBRL INSTANCE DOCUMENT cnce-20200806_htm.xml XML 11156
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36310 | Film No.: 201079776
SIC: 2834 Pharmaceutical Preparations